Access TOC
Get a SampleNovember 2024
The global bioreactors market size accounted for USD 11.79 billion in 2024, grew to USD 13.27 billion in 2025 and is projected to surpass around USD 38.55 billion by 2034, representing a healthy CAGR of 12.58% between 2024 and 2034.
The global bioreactors market size is exhibited at USD 11.79 billion in 2024 and is anticipated to reach around USD 38.55 billion by 2034, expanding at a CAGR of 12.58% between 2024 and 2034.
Bioreactors are the vessels and the manufacturing devices which are used for the biological reactions of different organisms like bacteria and yeast are grown or even animal cells are grown when these are subjected to the proper environment. The growth of this cell is maintained due to the sustainable environment in the formation of a product.
The biotechnology industry and the pharmaceutical industry makes use of bioreactors to produce biological products, antibodies and even vaccines. To subject or to cultivate different organisms' industrial processes also make use of bioreactors which are used for treating chronic diseases. Many pharmaceutical products make use of bioreactors in controlled conditions.
Monoclonal antibiotics have a great demand in various nations across the globe, due to which the bioreactors market is expected to see significant growth during the forecast. As the amount of funds received through government organizations and private organizations have grown in recent times in order to develop different types of vaccines for various diseases, the market will show subsequent growth. Single-use bioreactors also have a good demand, and it will generate a large amount of revenue in the long run.
The Pharmaceutical industry and the biotechnology sector make maximum use of bioreactors. As both of these industries are developing and increasing, the bioreactors market is also expected to grow. Technological development is also expected to play an instrumental role in the use of advanced bioreactors and various equipment of advanced nature. Cultivation parameters can be monitored through the help of screens, and all of these advanced features will lead to the growth of the market. Quality data can be collected and gathered through the use of such developments, and it also leads to less human intervention.
Advanced bioreactors are receiving more funds, and the market players are also engaged in the manufacturing of these bioreactors. Constant research and development activities in the field of bioreactors will help in the growth of the market. Clinical trials and preclinical trials have increased. Research and development activities for microbial applications and cell culture have also grown in recent times. All of these factors will lead to the growth of the market during the forecast period.
As there has been an increase in different types of chronic diseases across the globe like diabetes, cancer and cardiovascular diseases, the need for various therapies associated with all of these diseases will lead to the growth of the bioreactors market. The introduction of novel therapies for treating cancer will also create more demand for bioreactors.
| Report Coverage | Details |
| Market Size in 2024 | USD 11.79 Billion |
| Market Size by 2034 | USD 38.55Billion |
| Growth Rate from 2024 to 2034 | CAGR of 12.58% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2034 |
| Segments Covered | By Product Type, By Cell, By Molecule, By Usage and By End-Use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Development of preventive vaccines - In order to manufacture different types of vaccines that play a significant role in preventing various diseases will lead to the growth of the market. In recent times after the outbreak of the COVID-19 pandemic, the demand for COVID-19 vaccines had increased across the globe and the need for bioreactors of the clinical stage had also increased. Bioreactors were adopted on a large scale in various pharmaceutical industries for various procedures.
Organism cultivation - Bioreactors act as the apparatus for the cultivation of organisms like yeast, bacteria, animal cells and mammalian cells. All these are done in a controlled environment. Industrial processes also make use of bioreactors for the manufacturing of pharmaceutical products like monoclonal antibodies and vaccines. Biologicals are produced in a commercial way, and this also has a good application for bioreactors, due to which the adoption of this product will be more in the healthcare sector.
Technological advancements - In the coming years, market growth will be augmented by constant advancements in the features of the bioreactors and the processing of the bioreactors. Proactive involvement of the manufacturers of various nations in developing advanced technology which shall provide cost-effective bioreactors and help in the manufacturing of large-scale products, will lead to the growth of the market. There are many benefits associated with the use of advanced bioreactors, and all of these benefits will generate good revenue.
Processing large volumes of products and increasing the volume as much as possible with the use of advanced bioreactors. It enhances efficiency and it also simplifies the procedure. Single-use bioreactors have a greater adoption as this technology is better and provides good benefits for operations.
Low-capacity bioreactors - Many different types of bioreactors are available in the market, and the single-use ones have less capacity in any process and procedure, and this happens to pose a challenge in the growth of the market.
The reusable bioreactors segment is expected to generate maximum revenue which is estimated to be about 76%, as most organizations prefer reusable bioreactors and the growth in the adoption of these bioreactors for bulk manufacturing of products in the healthcare industry will increase revenue size. These bioreactors have a higher volume of capacity and better scalability which will eventually accelerate the market expansion.
The demand for single-use bioreactors will be more very flexible, and easy and quick deployment is needed. Cross-contamination is prevented with the use of single-use bioreactors, and as these bioreactors enhance safety, the market demand for single-use bioreactors will also grow. Single-use bioreactors are less expensive as compared to traditional bioreactors, and the implementation cost of these bioreactors is less.
Depending on the cells, the bioreactors market can be segmented into yeast cells, Mammalian cells, bacterial cells and a few other cells. The segment of mammalian cells will generate maximum revenue. The demand for bioreactors will be more due to the increased use of these cells in the commercial production and development of various vaccines and proteins that are used in therapeutic procedures. Viral analogs are also generated with the help of these cells, which are extremely significant for regenerative medicines, and this will be instrumental in increasing the revenue size of the bioreactors market.
The vaccine segment will dominate the market and will grow significantly in the coming years. Recently, the demand for COVID vaccines has increased drastically, due to which significant growth has been registered. Various disorders of a chronic nature and rare disorders have significantly increased the demand for bioreactors. Research and development activities conducted for developing different vaccines will accelerate market growth. Activity associated with the development of vaccines will stimulate market expansion.
The need for bioreactors in clinical trials and preclinical trials for developing various drugs will increase significantly during the forecast period. Bioreactors are used in the clinical segments, preclinical segments,s and developmental segments. Growth opportunities will be provided due to a growing number of cases of chronic diseases.
Rare diseases have also increased in recent times, and the development of drugs for such diseases will create more demand for bioreactors. Bioreactors of smaller scale will also have good demand in the market in order to develop new drugs that could treat rare diseases.
The biopharma manufacturer segment will have a larger market share which is estimated to be about 43%. Advanced technologies are adopted on a large scale in order to simplify manufacturing procedures due to which the need for such products will grow. Forthcoming years will see a maximum application of bioreactors in manufacturing and developing complex molecules like proteins and nucleic acids. As the number of pharmaceutical industries and biotechnology industries are going, the demand for
bioreactors will grow significantly. In developing nations, the capacity for manufacturing biopharmaceutical products is also increasing. The healthcare industry is expected to adopt more and more bioreactors and innovative products for various procedures. Intensive procedures adopted in modern times require the higher transfer of oxygen and efficient removal of carbon dioxide due to which the advanced by the actors will have a greater demand during the forecast period.
Significant growth rate to be registered in the North American region for the bioreactors industry. Prominent manufacturers are present in the North American region due to which the market growth will be substantial. The number of patients suffering with chronic diseases have also grown in recent times and the geriatric population is also increasing, due to which the demand for bioreactors will be more in the North American region.
The amount of expenditure made on research and development activities is also increasing in the North American region, and this will drive market growth in the forecast period. The facilities provided for conducting research and development activities are also favourable and it will show a significant increase. Such activities are supported by government investments as the demand for various vaccines has increased.
The development of the same after the outbreak of the COVID-19 pandemic has also grown. Good opportunities for the growth of the market will be provided by the North American region in the coming years.
By Product Type
By Cell
By Molecule
By Usage
By End-Use
By Geography
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
November 2024
November 2024
October 2022